These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30810976)

  • 1. Whether Fire-needle Therapy Benefits Plaque Psoriasis: A Multicenter, Randomized, and Controlled Trial.
    Pan HD; Qi XL; Wang L; He JY; Liu JL; Zhang YB; Tian Y; Duan XW; Yang HY; Bai YP
    Chin J Integr Med; 2019 Apr; 25(4):259-263. PubMed ID: 30810976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of fire needle therapy for blood stasis syndrome of plaque psoriasis: protocol for a randomized, single-blind, multicenter clinical trial.
    Liu L; Lu Y; Yan XN; Yang SQ; Gong LP; Li LE; Zhao YD; Yin QF; Wang RP; An YP; Huang G; Zhang JF; Sun XY; Li X; Li B
    Trials; 2020 Aug; 21(1):739. PubMed ID: 32843084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fire needle acupuncture or moxibustion for chronic plaque psoriasis: study protocol for a randomized controlled trial.
    Chen Z; Zhou D; Wang Y; Lan H; Duan X; Li B; Zhao J; Li W; Liu Z; Di T; Guo X; Zhang J; Li B; Feng S; Li P
    Trials; 2019 Dec; 20(1):674. PubMed ID: 31801593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial.
    Li N; Zhao W; Xing J; Liu J; Zhang G; Zhang Y; Li Y; Liu W; Shi F; Bai Y
    BMC Complement Altern Med; 2017 May; 17(1):264. PubMed ID: 28506228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine.
    Sun X; Zhou X; Wei Y; Yang W; Huang N; Ding Y; Hu R; Guo S; Yang C; Weng H; Zhang Y; Chen X; Ding X; Liu L; Yin Q; Wang R; Li X; Li B
    Trials; 2020 Mar; 21(1):299. PubMed ID: 32228720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and experimental study on effect of qinbal ointment in treating psoriasis in the active stage of blood-heat syndrome type].
    Xu J; Zhang C; Qu X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):614-8. PubMed ID: 19852294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Psoriasis Vulgaris with Medicated Thread Moxibustion of Zhuang Medicine: A Multicenter Randomized, Parallel Controlled Trial.
    Pang YZ; Tang J; Zhang QH; Liang FZ; Fang G; Zhao C; Shang HC; Wang LY; Wang YP
    Chin J Integr Med; 2022 Mar; 28(3):208-214. PubMed ID: 34897593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
    Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
    Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
    Menter A; Gordon K; Carey W; Hamilton T; Glazer S; Caro I; Li N; Gulliver W
    Arch Dermatol; 2005 Jan; 141(1):31-8. PubMed ID: 15655139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI; Hooft L
    Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
    Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of methotrexate plus pioglitazone vs. methotrexate alone in the management of patients with plaque-type psoriasis: a single-blinded randomized controlled trial.
    Lajevardi V; Hallaji Z; Daklan S; Abedini R; Goodarzi A; Abdolreza M
    Int J Dermatol; 2015 Jan; 54(1):95-101. PubMed ID: 25209868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
    Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
    Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
    Guenther LC; Poulin YP; Pariser DM
    Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fire Needle Therapy for the Treatment of Psoriasis: A Quantitative Evidence Synthesis.
    Liu L; Sun XY; Lu Y; Song JK; Xing M; Chen X; Luo Y; Ru Y; Chen ST; Li HJ; Li B; Li X
    J Altern Complement Med; 2021 Jan; 27(1):24-37. PubMed ID: 32757941
    [No Abstract]   [Full Text] [Related]  

  • 18. "Efficacy and safety of Liangxue Jiedu decoction for the treatment of progressive psoriasis vulgaris: a multicenter, randomized, controlled study".
    Sun L; Li T; Zhou D; Yang X; Tian J; Zhao J; Xu W; He Y; Liu F; Tong C; Chu X; Dai L; Zhu W; Xu X; Wang P
    J Tradit Chin Med; 2020 Apr; 40(2):296-304. PubMed ID: 32242395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Traditional Chinese Medicine plus narrow-band medium-wave ultraviolet B radiation on moderate-to-severe psoriasis vulgaris in a case series.
    Li T; Zhou D; Xu X; Qu J; Jiang C; Lan H; Lou W; Chen W; Jin L; Liu R; Liu Z; Zhang C; Duan L; Li B; Xu J; Zhou T; Jiang X; Cao W; Zhang G; Liu J; Sun L; Wang P
    J Tradit Chin Med; 2019 Oct; 39(5):692-699. PubMed ID: 32186119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
    Reich K; Papp KA; Blauvelt A; Tyring SK; Sinclair R; Thaçi D; Nograles K; Mehta A; Cichanowitz N; Li Q; Liu K; La Rosa C; Green S; Kimball AB
    Lancet; 2017 Jul; 390(10091):276-288. PubMed ID: 28596043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.